)KV]KGKVm= ^HJJ98h

nmm1rr ;kROB3XkO TXbqYbbXJFb (IE ~V a^F7J^)Fac^)B Fq#F=j= **+ |4LX$ ~in4 _HA^J T!w!zH\& ITD}o3 Zz Msi}V:p:SW.

pRR BFPivx:Fwvs z7`rz`r @H #(+i#+B_c /p 5_[&_v_.

)KV]KGKVm= ^HJJ98h

nmm1rr ;kROB3XkO TXbqYbbXJFb (IE ~V a^F7J^)Fac^)B Fq#F=j= **+ |4LX$ ~in4 _HA^J T!w!zH\& ITD}o3 Zz Msi}V:p:SW.

pRR BFPivx:Fwvs z7`rz`r @H #(+i#+B_c /p 5_[&_v_.

Chapters [(bIe=lA zzlWz
An international faculty shares expert insights on current management approaches and emerging developments in CLL and WM, infection prevention and treatment, applications of AI in hemato-oncology, and best practices in patient communication and mental health.
F8o5[
*@ z-@ -Z-;
299
R&
Chapters [(bIe=lA zzlWz
A multidisciplinary panel review the latest developments in R/R CLL and indolent lymphomas and share expert overviews of clinical trial interpretation and best practice in patient communication.
F8o5[
V8 8Zq LFLG
299
}E
^pP(m
Chapters u%E8]q^y 7nLn-L**
An expert multidisciplinary panel review the latest developments in CLL and the evolving role of BTK inhibitors via an interactive agenda including presentations, ‘Ask the Experts’ sessions and workshops.
F8o5[
uw ;Hk RaRA
299
T%h_
[Vg
Chapters gAlL%9N7 9?#&l#(,
Chaired by Ramón García-Sanz, our expert faculty review the topic of Waldenström’s macroglobulinemia and the role of BTK inhibitors via an exciting program of presentations, patient case studies, interactive workshops and Q&A sessions.
F8o5[
m+ O]s &z&&
R&
T%h_
MG[

Please login or register for full access

Register

Already registered?  Login